AGOURA HILLS, Calif., Oct. 06, 2022 Oncotelic Therapeutics, Inc , directly and / or through its wholly owned subsidiaries Oncotelic Inc. and PointR Data Inc., a developer of treatments for rare. | October 6, 2022
Oncotelic Presenting Data for OT101 Against Diffuse Intrinsic Pontine Glioma (DIPG) at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
North American Morning Briefing: Stock Futures -2- morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
AGOURA HILLS, Calif., Aug. 17, 2022 Oncotelic Therapeutics, Inc. , developer of treatments for rare and orphan indications, including Parkinson Disease and various cancers, today announced that. | August 17, 2022